H Barton Grossman Selected Research

H Barton Grossman Research Topics

Disease

100	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 06/2002
61	Neoplasms (Cancer) 01/2021 - 09/2002
17	Carcinoma (Carcinomatosis) 01/2022 - 09/2003
15	Non-Muscle Invasive Bladder Neoplasms 01/2021 - 03/2006
11	Transitional Cell Carcinoma 01/2011 - 06/2003
5	Neoplasm Metastasis (Metastasis) 11/2014 - 08/2003
4	Aneuploidy (Aneuploid) 10/2008 - 09/2002
4	Prostatic Neoplasms (Prostate Cancer) 12/2005 - 02/2004
3	Disease Progression 11/2016 - 07/2007
3	Lymphatic Metastasis 04/2015 - 12/2012
3	Carcinoma in Situ 01/2008 - 06/2006
2	Hernia (Hernias) 06/2014 - 08/2005
2	Carcinogenesis 08/2010 - 04/2008
2	Hematuria 07/2010 - 02/2008
2	Stomach Neoplasms (Stomach Cancer) 06/2010 - 03/2010
2	Margins of Excision 09/2009 - 01/2009
2	Residual Neoplasm 09/2007 - 08/2003
1	Obesity 01/2021
1	Rare Diseases (Rare Disease) 08/2013
1	Myocardial Infarction 02/2013
1	Hydronephrosis 02/2013
1	Pneumonia (Pneumonitis) 02/2013
1	Hearing Loss (Hearing Impairment) 02/2013
1	Thrombocytopenia (Thrombopenia) 02/2013
1	Vomiting 02/2013
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 12/2010
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2010
1	Hepatocellular Carcinoma (Hepatoma) 06/2010

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 10/2014 - 09/2002
9	Biomarkers (Surrogate Marker)IBA 01/2019 - 09/2002
8	5-aminolevulinic acid hexyl ester FDA Link 04/2016 - 07/2007
7	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2003
6	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2013 - 08/2003
5	nuclear matrix protein 22IBA 10/2011 - 02/2005
4	InterferonsIBA 11/2016 - 12/2004
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2011 - 03/2003
4	EnzymesIBA 03/2010 - 02/2003
4	SmokeIBA 09/2008 - 12/2004
4	DNA (Deoxyribonucleic Acid)IBA 07/2008 - 09/2002
4	FenretinideIBA 01/2008 - 06/2002
4	Epoxy Compounds (Epoxides)IBA 03/2006 - 04/2003
4	Benzo(a)pyreneIBA 03/2006 - 04/2003
4	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA 03/2006 - 04/2003
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018 - 09/2004
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2011 - 03/2003
3	Celecoxib (Celebrex)FDA Link 10/2011 - 09/2002
3	Vinblastine (Vinblastine Sulfate)FDA Link 09/2011 - 08/2003
3	Methotrexate (Mexate)FDA LinkGeneric 09/2011 - 08/2003
3	Phosphotransferases (Kinase)IBA 08/2010 - 09/2002
3	LigandsIBA 08/2006 - 03/2003
3	Messenger RNA (mRNA)IBA 10/2005 - 05/2004
2	Indicators and Reagents (Reagents)IBA 11/2016 - 10/2016
2	Ifosfamide FDA LinkGeneric 02/2013 - 06/2009
2	TOR Serine-Threonine KinasesIBA 08/2010 - 04/2010
2	Tumor Biomarkers (Tumor Markers)IBA 06/2010 - 12/2005
2	VitaminsIBA 11/2008 - 09/2002
2	CarcinogensIBA 09/2008 - 01/2007
2	Matrix Metalloproteinases (MMPs)IBA 05/2007 - 12/2006
2	RetinoidsIBA 09/2006 - 01/2005
2	Monoclonal AntibodiesIBA 02/2006 - 09/2002
2	Nuclear Matrix-Associated ProteinsIBA 01/2006 - 02/2005
2	ImmunosorbentsIBA 07/2005 - 02/2003
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2005 - 12/2004
2	Connexin 26IBA 02/2004 - 03/2003
2	ParaffinIBA 03/2003 - 09/2002
2	Formaldehyde (Formol)FDA Link 03/2003 - 09/2002
1	A 17 (A-17)IBA 11/2016
1	Interleukin-12 (IL 12)IBA 01/2016
1	CytokinesIBA 01/2016
1	Cyclin EIBA 10/2014
1	Genetic Markers (Genetic Marker)IBA 10/2014
1	Photosensitizing Agents (Photosensitizers)IBA 10/2014
1	Excipients (Suspending Agents)IBA 09/2013
1	Gemcitabine FDA Link 02/2013
1	Anesthetics (Anesthetic Agents)IBA 02/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2013
1	AminesIBA 10/2012
1	Urea (Carbamide)FDA LinkGeneric 11/2011
1	Complement System Proteins (Complement)IBA 09/2011
1	PlatinumIBA 09/2011
1	Everolimus FDA Link 05/2011
1	P-2 (P 2)IBA 10/2010

Therapy/Procedure

39	Cystectomy 01/2019 - 06/2003
26	Therapeutics 01/2022 - 06/2002
17	Neoadjuvant Therapy 01/2019 - 08/2003
11	Drug Therapy (Chemotherapy) 02/2013 - 06/2003
6	Immunotherapy 01/2021 - 05/2003
6	Chemoprevention 11/2008 - 09/2002
5	Intravesical Administration 07/2007 - 06/2003
4	Nephroureterectomy 11/2013 - 12/2006
3	Aftercare (After-Treatment) 09/2013 - 06/2002
3	Lymph Node Excision (Lymph Node Dissection) 12/2012 - 06/2003
2	Anesthesia 04/2015 - 09/2007
2	Urinary Diversion (Ileal Conduit) 06/2014 - 07/2010
2	Combination Drug Therapy (Combination Chemotherapy) 09/2011 - 11/2006
2	Adjuvant Chemotherapy 01/2009 - 01/2008
2	Radiotherapy 03/2006 - 04/2004
1	Conservative Treatment 04/2015
1	Sutures (Suture) 06/2014
1	Operative Time 07/2011